BANGALORE, India, April 30, 2012 /PRNewswire/ --
I-SMART (Indian Society For Molecular Advanced Regenerative Technologies) a conglomerate of Indian scientists from DRDO, DST, Dr.Agarwal Hospitals, Manacells, Gene Research Foundation has organized the first Gene Therapy Convention to be held at Bangalore on May 2nd 2012.
People who are interested are welcome to contact Dr.Agarwal Hospitals for registrations. Address: Dr.Agarwal Hospitals 15, Eagle ST, Bangalore 560025, Phone 080-22240736, 22240200, 22221242, mobile +91-9845010510, 9845039271, 9844202364 email [email protected] The conference will shed new light into the frontiers of medicine where patients can be addressed with healthy DNA from their own blood.
I-SMART Millenium Awards will be presented to the national heroes, Dr.V.K.Saraswat (Chief of DRDO), Sri Oscar Fernandes (MP), Sreesanth (Cricketeer), Pujya Swamy Chidanand Saraswati (Parmarth Niketan, Rishikesh) Dr. Ramasami (Sec DST), On May 2nd 4 pm 2012, Bangalore.
DNA-Gene therapy uses peripheral blood from the patients finger with Mana (DNA Activator) to generate the patients own healthy or fetal DNA. This is the molecule responsible for creating a particular human body and thus it can also repair and regenerate the respective aging person. Thus customization of medical technologies has made it possible to treat various conditions associated with diseases of the eye, neurological disorders, diabetes, hypertension, cancer etc.
The work on this line of treatment was initiated over 20 years back by Dr.Agarwal Hospitals and Gene Research Foundation, with the help of The Department of Science & Technology, Govt. of India. For over 6 years Mana DNA gene therapy and the Defence Research Development Organization have added value to medical science.They have used high tech instrumentation and microscopes to show DNA formation within seconds of one drop of patients blood and Mana (DNA activator) coming together.
Through Dr.Agarwal Hospitals this medication has been used on eye patients (most of them are associated with a general disease) with great success. Over the last 8 years and 12000 patients using the patients own blood (autologous) shows no side effects or allergic reactions. This has taken a new step into medical technologies by giving it customization of each individual patient and seems to be one single major breakthrough in making the treatment a success.
After two days of debate and discussion the first Gene Therapy Convention I-SMART 2012 will be brought into mass production to reach out to soldiers on the front (DRDO), and the masses (DST, through Manacells. An expansion plan to the tune of 300 cr is required and investors are welcome to come in at this stage. Over 100cr will go into a high end research facility which will monitor the mass production as well as be open to other sources.
The research facility hopes to bring genome mapping at the fingertips of the patients. This activity can not only detail out the defect a patient has but can also predict if and when a patient can have a particular disease. This will be a strong, predictive, investigative and prognostic tool in the hands of our medical fraternity. With the treatment of Mana on the same patient, genome mapping can be repeated again and the doctor can assess the patients treatment.
The next frontier in medicine has been possible through the research and development of Dr.Agarwal Hospials and Gene Research Foundation. With investments into Manacells through mass production it will be available to the masses. A completely Indian enterprise where treatment is possible to worst case scenarios. Prognosis of every disease in relation to a particular patient through his specific DNA can be made available. Lines of treatment and prevention can be started in disease and in the prevention of disease.
Primary Media Contact : Pankaj Sondhi, [email protected], +91-9845010510